Graft-versus-host disease in recipients of syngeneic bone marrow
Gluckman, E.; Devergie, A.; Sohier, J.; Saurat, J.H.
Lancet 1(8162): 253-254
1980
ISSN/ISBN: 0140-6736 PMID: 6101698 Document Number: 154817
Document emailed within 1 workday
Related Documents
Cooper, M.H.; Hartman, G.G.; Starzl, T.E.; Fung, J.J. 1991: The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506 Transplantation Proceedings 23(6): 3234-3235Liem, L.M.; van Noort, J.T.; Goulmy, E. 1996: Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin a Bone Marrow Transplantation 18(1): 73-78
Spaner, D.; Lowsky, R.; Fyles, G.; Lipton, J.H.; Banerjee, D.; Ng, C.M.; Wade, J.A.; Messner, H.A. 1998: Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient Transplantation 66(9): 1251-1253
Dale, B.M.; Atkinson, K.; Kotasek, D.; Biggs, J.C.; Sage, R.E. 1989: Cyclosporine-induced graft vs host disease in two patients receiving syngeneic bone marrow transplants Transplantation Proceedings 21(5): 3816-3817
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Tollemar, J.; Ringdén, O.; Heimdahl, A.; Lönnqvist, B.; Sundberg, B. 1988: Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate Transplantation Proceedings 20(3 Suppl 3: 470-479
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Izzi, T.; Lucarelli, G. 1983: Bone marrow transplantation in humans. IV. the graft versus host disease Recenti Progressi in Medicina 74(6): 720-732
Champlin, R. 1992: Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation Seminars in Hematology 29(3 Suppl 2): 46-52
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E. 1988: Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease Birth Defects Original Article Series 23(5b): 313-316
Barbara, J.A.; Thomas, A.C.; Smith, P.S.; Gillis, D.; Ho, J.O.; Woodroffe, A.J. 1992: Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient Clinical Nephrology 37(3): 115-118